Generation bio to present at 39th annual j.p. morgan healthcare conference

Cambridge, mass., jan. 05, 2021 (globe newswire) -- generation bio co. (nasdaq: gbio), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that the company will present at the virtual 39th annual j.p. morgan healthcare conference on tuesday, jan. 12, 2021.
GBIO Ratings Summary
GBIO Quant Ranking